Abstract
BackgroundDespite increasing prevalence of gout in the UK (1), a variety of barriers result in suboptimal care (1,2) with only 40% of gout patients receiving urate-lowering therapy (ULT), usually at...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have